Medical Plastics Market: Hybrid Molding Methods Improving Part Efficiency

The global medical plastics market size was estimated at USD 52.9 billion in 2023 and is projected to reach USD 87.58 billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030. Market growth is primarily driven by the continuous development of advanced plastics and composite materials used in the manufacturing of medical components such as catheters, surgical instrument handles, implants, and syringes. The increasing adoption of high-performance plastics like polyethylene (PE), polypropylene (PP), and polycarbonate (PC) in medical applications highlights their advantages, including biocompatibility, durability, lightweight nature, and cost efficiency.

The expanding home healthcare sector is further propelling demand for medical plastics, as patients and healthcare providers increasingly favor at-home medical care for its affordability, convenience, and safety. The COVID-19 pandemic accelerated this shift, with patients preferring in-home treatments over hospital or nursing home care. According to the Medicaid and CHIP Payment and Access Commission (MACPAC), the annual cost for home care averages around USD 26,000, compared to approximately USD 90,000 for nursing home care. This significant cost advantage, coupled with the growing adoption of portable and disposable medical devices, continues to fuel demand for plastic-based medical solutions.

Moreover, the rising government investment in healthcare infrastructure and advancements in medical packaging and disposable equipment are expected to further support industry expansion. Medical-grade plastics are increasingly being used for sterile packaging, diagnostic equipment, and prosthetics, owing to their superior sterilization resistance, chemical stability, and recyclability.

Key Market Trends & Insights

• North America dominated the global market with a share of over 33.0% in 2023.
• By application, the medical components segment held a dominant revenue share of over 40.0% in 2023.
• By product, the polyphenylsulfone (PPSU) resin segment accounted for the largest revenue share of over 51.0% in 2023.

Download a free sample PDF of the Medical Plastics Market Intelligence Study by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 52.9 Billion
• 2030 Projected Market Size: USD 87.58 Billion
• CAGR (2024–2030): 7.4%
• North America: Largest market in 2023

Competitive Landscape

The global medical plastics market is characterized by strong competition, with leading players focusing on strategic acquisitions, product innovation, and sustainability initiatives to expand their market share.

• In November 2022, Celanese Corporation completed the acquisition of DuPont’s Mobility & Materials (M&M) business for USD 11 billion, enabling Celanese to strengthen its global presence and expand offerings in sustainable and high-performance materials.
• In June 2023, SABIC acquired Clariant’s 50% stake in Scientific Design, a leader in catalysis technology. This acquisition reinforced SABIC’s position in technology-driven, non-cyclical industries and enhanced its expertise in specialty materials.

Prominent Companies Include

• Röchling SE & Co. KG
• Nolato AB
• Saint-Gobain
• SABIC
• Orthoplastics Ltd
• Eastman Chemical Company
• Celanese Corporation
• Dow, Inc.
• Tekni-Plex, Inc.

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.

Conclusion

The medical plastics market is poised for significant growth through 2030, supported by the rising demand for lightweight, durable, and biocompatible materials in medical applications. The increasing emphasis on home healthcare, single-use medical devices, and sustainable production practices is reshaping the industry landscape. With continued technological advancements and strong investment from key players, medical plastics are expected to remain integral to the evolution of next-generation medical devices and healthcare solutions worldwide.